Emergent BioSolutions Inc.EBSNYSE
LOADING
|||
Switch Symbol:
Revenue Growth Accelerating
Trending higher, above historical average, strong compound growth.
Left:
||||
Year-over-year revenue growth rate
Latest
64.02%
↑ 582% above average
Average (39q)
9.39%
Historical baseline
Range
High:119.82%
Low:-57.48%
CAGR
+11.6%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | 64.02% |
| Q2 2025 | -36.59% |
| Q1 2025 | 14.12% |
| Q4 2024 | -33.73% |
| Q3 2024 | 15.35% |
| Q2 2024 | -15.21% |
| Q1 2024 | 8.60% |
| Q4 2023 | 2.26% |
| Q3 2023 | -19.95% |
| Q2 2023 | 105.66% |
| Q1 2023 | -50.24% |
| Q4 2022 | 37.64% |
| Q3 2022 | 0.00% |
| Q2 2022 | -21.98% |
| Q1 2022 | -57.48% |
| Q4 2021 | 119.82% |
| Q3 2021 | -17.23% |
| Q2 2021 | 15.89% |
| Q1 2021 | -41.17% |
| Q4 2020 | 51.35% |
| Q3 2020 | -2.41% |
| Q2 2020 | 105.04% |
| Q1 2020 | -42.74% |
| Q4 2019 | 7.83% |
| Q3 2019 | 28.21% |
| Q2 2019 | 27.60% |
| Q1 2019 | -29.59% |
| Q4 2018 | 55.93% |
| Q3 2018 | -21.16% |
| Q2 2018 | 86.93% |
| Q1 2018 | -39.23% |
| Q4 2017 | 29.71% |
| Q3 2017 | 48.29% |
| Q2 2017 | -13.77% |
| Q1 2017 | -22.95% |
| Q4 2016 | 6.12% |
| Q3 2016 | 56.63% |
| Q2 2016 | -11.39% |
| Q1 2016 | -35.56% |
| Q4 2015 | 0.89% |